Financial Ratios

GANGA PHARMACEUTICALS LTD.

NSE : NABSE : 539680ISIN CODE : INE615T01017Industry : Pharmaceuticals & DrugsHouse : Private
BSE23.500 (0 %)
PREV CLOSE ( ) 23.50
OPEN PRICE ( ) 23.50
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 8000
TODAY'S LOW / HIGH ( )23.50 23.50
52 WK LOW / HIGH ( ) 7.528.49
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)0.100.090.050.460.46
   CEPS(Rs)0.240.230.180.600.59
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)13.4213.3213.2313.1812.69
   Tax Rate(%)26.0026.0045.5826.0027.61
Margin Ratios
   Core EBITDA Margin(%)0.181.691.3912.5512.45
   EBIT Margin(%)9.549.889.8416.1615.16
   Pre Tax Margin(%)2.052.061.588.287.69
   PAT Margin (%)1.521.520.866.135.56
   Cash Profit Margin (%)3.693.723.127.897.14
Performance Ratios
   ROA(%)0.490.480.272.462.34
   ROE(%)0.720.700.383.593.70
   ROCE(%)3.383.413.367.187.26
   Asset Turnover(x)0.320.320.310.400.42
   Sales/Fixed Asset(x)1.931.881.812.382.64
   Working Capital/Sales(x)0.800.770.801.101.39
Efficiency Ratios
   Fixed Capital/Sales(x)0.520.530.550.420.38
   Receivable days125.67125.49145.29136.16152.45
   Inventory Days164.60167.38166.98130.01124.61
   Payable days155.50136.81149.85164.37313.87
Valuation Parameters
   PER(x)0.00109.870.0015.170.00
   PCE(x)0.0044.920.0011.790.00
   Price/Book(x)0.000.770.000.530.00
   Yield(%)0.000.00
   EV/Net Sales(x)2.272.442.431.411.69
   EV/Core EBITDA(x)19.3420.1820.097.8410.13
   EV/EBIT(x)23.7524.6824.718.7011.18
   EV/CE(x)0.730.760.750.570.73
   M Cap / Sales0.001.670.000.930.00
Growth Ratio
   Net Sales Growth(%)3.914.83-22.88-8.4410.16
   Core EBITDA Growth(%)0.734.66-47.91-1.9720.36
   EBIT Growth(%)0.315.27-53.03-2.4224.72
   PAT Growth(%)3.7486.16-89.220.8799.05
   EPS Growth(%)3.7486.21-89.220.8799.05
Financial Stability Ratios
   Total Debt/Equity(x)0.340.360.320.280.36
   Current Ratio(x)2.722.912.862.732.24
   Quick Ratio(x)2.092.232.152.091.65
   Interest Cover(x)1.271.261.192.052.03
   Total Debt/Mcap(x)0.460.51

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.